The tape was reading the calendar, not the quarter. Oklo closed at $23.55 on Nov. 6, up 22.7%, on a release that showed $1.861 million of revenue, $772,000 of gross profit and a $41.746 million net loss — its first revenue in company history, earned for engineering, design and licensing-support work by two firms it acquired in June, not by a reactor.
The revenue \"beat\" is a consensus artifact. Against the $1.01 million consensus carried by some trackers, $1.86 million is an 80% beat; against the roughly $1.88 million Zacks used, it is a 1.2% miss. Neither framing survives contact with a company whose trailing revenue is $3.07 million and whose equity is a bet on dates. What the market bought on Nov. 6 was a set of dates: the NRC's final rule, effective Nov. 25, letting commercial licensees reuse analysis from Energy Department-authorized reactors; a forging-capacity reservation with U.S. Forged Rings; and 900 megawatts sitting in PJM's 2026 interconnection cluster study.
Revenue, Q3 2026
$1.86M
Three months ended Sept. 30, 2026; the first revenue in company history, all from services firms acquired in June
Diluted loss per share
-$0.22
Q3 2026; a $41.7 million net loss versus $29.7 million a year earlier
Cash and marketable securities
$3.13B
At Sept. 30, 2026, with no funded debt and $120.0 million of total liabilities
Nov. 6 close
$23.55
Up 22.7% on the day, yet still about 75% lower year to date
Shares issued, Q3 2026
$402.3M
Stock sold in the quarter alone, after roughly $2.26 billion through nine months
PJM queue
900 MW
Under active consideration in PJM's 2026 interconnection cluster study
The print
The tape was reading the calendar, not the quarter
The quarter's cash statements matter more than its income statement, and both point the same way. Oklo used $45.5 million of operating cash and $154.0 million of capital expenditure in the September quarter, for $199.5 million of free cash outflow, and covered it with $402.3 million of stock issuance. Operating expenses of $83.2 million — $41.6 million of research and development and $41.6 million of general and administrative — ran against $1.86 million of revenue.
Interest income of $27.9 million did more to shape the headline loss than anything the company sold, which is the clearest signal that this is a financing story right now, not an operating one.
| Line item | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | $1.86M | $0 |
| Gross profit | $0.77M | $0 |
| Operating expenses | $83.2M | $36.3M |
| Loss from operations | -$82.4M | -$36.3M |
| Interest income | $27.9M | $7.1M |
| Net loss | -$41.7M | -$29.7M |
| Diluted loss per share | -$0.22 | -$0.20 |
| Operating cash flow | -$45.5M | -$18.0M |
| Capital expenditure | -$154.0M | -$5.0M |
| Free cash flow | -$199.5M | -$23.1M |
| Common stock issued | $402.3M | $0 |
| Weighted-average diluted shares | 188.6M | 150.4M |
Nov. 6, 2026 one-day moves across the AI-power chain
U.S. policy-linked nuclear names repriced on the Oklo print; the Korean nuclear hardware maker went the other way. Percentage change from the Nov. 5 close.
Unit: %
Closed at $23.55
22.7
Closed at $104.60
17.5
Closed at $124.80
10.6
Closed at $610.15
0.8
Closed at KRW 44,700
-9.3
What repriced
Every dollar of the rally bought a dated milestone
The mechanism is regulatory sequencing, and it changed three weeks before the print. On Oct. 22 the Nuclear Regulatory Commission finalized a rule amending 10 CFR Parts 50 and 53 so that applicants can lean on analyses, test data and other information from Energy Department- and War Department-authorized demonstration reactors when they apply for a commercial license — 136 unique comments in, and effective 30 days after Federal Register publication, which Oklo's own filing puts at Nov. 25, 2026.
That single change converts everything Oklo has done on the Energy Department side into licensing currency. The Aurora powerhouse under the Department's Reactor Pilot Program, the Groves test reactor's startup authorization and criticality, the preliminary documented safety analysis approved for Aurora-ID on June 11, 2026 — all of it becomes evidence a commercial applicant can reuse. The company no longer needs the NRC's patience as much as it needs a calendar it can point at.
This rule delivers the EO 14300 vision for an expedited path from DOE and DOW projects to NRC commercial licensing.
| Date | Milestone | What it de-risks | Who captures the value |
|---|---|---|---|
| Oct. 22-26, 2026 | NRC final rule on reusing Energy Department reactor data in commercial licensing, effective Nov. 25 | Turns Department work into licensing evidence | Oklo and every other developer |
| June 11, 2026 | Department of Energy approved the preliminary documented safety analysis for Aurora-ID | Safety case for a first commercial build | Oklo and its engineering chain |
| Aug. 3 / Sept. 24, 2026 | PJM withdrew Oklo's 750 MW project from Cycle 01; FERC denied Oklo's complaint, though a cure into Cycle 02 or the expedited track remains open | Nothing yet — it sets the queue path back | Oklo, and anyone competing for the same interconnection slots |
| Q3 2026 | 900 MW under active consideration in PJM's 2026 cluster study | Interconnection, the gate to selling any power | Oklo |
| Nov. 6, 2026 | Domestic forging capacity reserved with U.S. Forged Rings for reactor vessels and lids; first deliveries 2030, capacity through 2035 | The forging bottleneck ahead of the build | U.S. Forged Rings, a private company |
| Q3 2026 | Roughly $6.8 million ARPA-E FORGE award with Idaho National Laboratory for recycled-metal fuel | The fuel-recycling pathway | Oklo and the national labs |
| June 18, 2026 | Centrus letter of intent: enough HALEU for up to five Aurora powerhouses, deliveries from 2029, prepayments possible | Fuel for the first five reactors | Centrus, with DOE contracts behind it |
| Jan. 9, 2026 | Meta agreements: up to 1.2 GW for Oklo in Pike County, possibly online as early as 2030 and fully targeted by 2034 | Demand, with reservation capacity backed by Meta capital | Meta, buying optionality it is not obliged to build |
| Dec. 18, 2024 | Switch master agreement for up to 12 GW of advanced nuclear power | Framework volume only | Nobody yet — it is non-binding |
The gates
Fuel arrives in 2029, and the queue already bit once
- Fuel is the binding constraint: the June 18, 2026 Centrus letter of intent covers high-assay low-enriched uranium for up to five Aurora powerhouses, with deliveries scheduled to begin in 2029 and prepayments from Oklo contemplated.
- The fuel lands in the same county as the customer: Centrus would supply from its American Centrifuge Plant at Piketon, Ohio, while Oklo's 1.2 GW Meta campus sits in Pike County — one county, one 2029 fuel date, one interconnection queue.
- The queue has already cost Oklo once: PJM pulled a 750 MW project from interconnection Study Cycle 01 on Aug. 3 over unresolved modeling deficiencies, and FERC denied Oklo's complaint on Sept. 24, leaving a cure into Cycle 02 or the expedited track as the only path back.
- Management's own sequencing is long: the documented safety analysis for Aurora-ID is described as unlikely before roughly 2028, followed by a readiness review and startup authorization, and power can only be sold under Department authorization, to laboratories first, before any commercial license.
- One customer is funding the wait, and it has not committed to build: management said the Meta agreement is not binding as to constructing the reactor, though it does bind capacity reservation supported by Meta capital — optionality, with capital behind it.
The cost
The schedule is being bought with stock
Set the balance sheet against the market value and the arithmetic becomes stark. At the Nov. 6 close, Oklo's market capitalization was about $4.38 billion against $3.13 billion of cash and marketable securities, leaving roughly $1.25 billion of value attached to a business with $3.07 million of trailing revenue. Strip out the cash and the option on the whole pipeline is priced at roughly 400 times sales.
That is not a balance-sheet problem; it is a financing plan. Oklo raised about $2.26 billion of equity in nine months, and the weighted-average diluted share count rose28.8% to 188.6 million. Every quarter of waiting is paid for in stock, and the stock is down about 75% year to date, so the issuance is happening at a discount to where the company was valued twelve months ago.
Free cash flow, 9M 2026
-$391.8M
Operating cash use of $110.9 million plus $280.9 million of capital expenditure
Value left after cash
$1.25B
Market capitalization of $4.38 billion less $3.13 billion of cash and marketable securities
Trailing sales multiple
~400x
What remains after cash, measured against $3.07 million of trailing revenue
Runway at the Q3 burn rate
~4 years
Cash and marketable securities divided by the quarter's $199.5 million of free cash outflow
Operating cash use, 9M 2026
$110.9M
Against company guidance of $120 million to $150 million for the full year
Stockholders' equity
$3.65B
Against $120.0 million of total liabilities and no funded debt
Oklo quarterly free cash flow, $ millions
Cash burn at Oklo accelerated almost every quarter of 2026 as construction spending ramped; nine-month free cash outflow reached $391.8 million.
Unit: $ millions
Q1 2026
-50.7
Q2 2026
-141.7
Q3 2026
-199.5
The third leg
The third leg sells the same electrons years later, at 400 times the price
Meta's January basket is the cleanest illustration of the structure. The company committed to up to 6.6 GW of nuclear capacity: more than 2.1 GW of life extension and uprates from Vistra's Perry and Davis-Besse, 2.8 GW of TerraPower Natrium capacity, and up to 1.2 GW from Oklo in Pike County, possibly online as early as 2030 and fully targeted by 2034. The first two sell electrons in the late 2020s; the third sells a license that does not exist yet.
The market knows the difference and prices it accordingly. Across the chain, the businesses that already sell electrons or the hardware to build them change hands at roughly two to five times trailing sales, while the two listed developers change hands in the hundreds of times.
| Company | What it sells | Trailing revenue | Market value | Market value ÷ trailing sales | Nov. 6 close |
|---|---|---|---|---|---|
| Meta | The buyer: capital, offtake and up to 6.6 GW of nuclear commitments | $241.6B | $1,559.7B | 6.5x | $610.15 |
| Constellation Energy | 32.4 GW of operating nuclear already selling firm power to data centers | $31.3B | $88.6B | 2.8x | $249.95 |
| Vistra | Life extension and uprates under a Meta offtake at Perry and Davis-Besse | $19.2B | $41.9B | 2.2x | $124.80 |
| BWX Technologies | Nuclear components, fuel fabrication, medical isotopes and stockpile conversion | $3.60B | $11.0B | 3.1x | $120.12 |
| Centrus | HALEU enrichment: $5.4B enrichment backlog, $7.0B total through 2040 | $455M | $2.06B | 4.5x | $104.60 |
| NuScale Power | An NRC-approved design and a Doosan module contract, but $281K of quarterly revenue | $2.73M | $2.08B | ~760x | $5.08 |
| Oklo | A licensing roadmap: 900 MW in PJM's cluster study, fuel from 2029, components from 2030 | $3.07M | $4.38B | ~1,430x | $23.55 |
Horizons
Two clocks: months for the tape, years for the fuel
- Nov. 9, 2026 — Constellation Energy reports third quarter: the operating-fleet read on hyperscaler demand, and the cleanest test of whether AI power is being priced on electrons or on options.
- Nov. 25, 2026 — the NRC data-reuse rule takes effect, opening a licensing path that runs through Department of Energy-authorized evidence rather than a fresh docket.
- PJM's 2026 cluster study: decisions on the 900 MW under consideration, and whether Oklo cures the 750 MW project's modeling deficiencies into Cycle 02 or the expedited track.
- Oklo's fourth-quarter report in February 2027: services revenue from ARMEC and CEI, the pace of at-the-market issuance, and whether the $120 million to $150 million operating cash-use guide holds.
- Centrus' fourth quarter and the fiscal 2027 appropriations fight over operating the HALEU cascade, which puts roughly $0.8 billion of Centrus technical-solutions backlog at risk.
- 2028 — Aurora-ID documented safety analysis, then a readiness review and startup authorization; management's own sequencing puts the safety case roughly four years out, ahead of any commercial license.
- 2029 — first Centrus HALEU deliveries to Oklo, enough for up to five Aurora powerhouses, with prepayments still to be negotiated in a definitive agreement.
- 2030 — first U.S.-forged reactor vessels and lids from Hertford County, North Carolina, in the same window Meta has floated for the first phase of the Pike County campus.
- 2030-2034 — the point where a calendar becomes power sales against Meta's PJM load, if the safety analysis, the fuel and the queue all arrive in order.
- The bear clock: if the new rule produces no Oklo license application by mid-2027, or if commercial HALEU slips past 2029, the milestone premium compresses toward the roughly $16.80 a share of cash and marketable securities underneath it.
Verdict
What would break this
The facts are narrow and checkable: $1.86 million of revenue, a $41.7 million net loss, $3.13 billion of cash and marketable securities, $402.3 million of stock sold in the quarter, a final NRC rule effective Nov. 25, a forging reservation with deliveries from 2030, a fuel letter of intent with deliveries from 2029, 900 megawatts under interconnection consideration, and a 750 megawatt project withdrawn from the first study cycle with the complaint denied.
The inference is that the market has re-rated this leg on de-risking steps rather than on power, and that this is a policy transmission channel: hyperscaler capital is underwriting federal policy that in turn underwrites developer equity, and the developer equity is the most expensive, most dilutive place to hold that view. The further inference — that any of it converts to cash — is speculation with a 2029 fuel date and a 2028 safety analysis in front of it.
What breaks the case is specific: a license application that does not arrive, fuel that does not move, a queue that does not reopen, and dilution that continues at a quarter a year while the stock sits75% below its highs. What would strengthen it is the opposite: the first application built on Department of Energy data, a definitive fuel agreement with prepayment, and a PJM cluster study that converts900 megawatts into a firm position.
How to hold the same buildout at a lower multiple
- The market paid for a calendar, not meters: the NRC data-reuse rule takes effect Nov. 25 and $3.13 billion of cash and marketable securities funds the wait.
- The pipeline is still paper: 900 MW under interconnection consideration, a Meta agreement not binding to build, and Centrus fuel from 2029.
- Dilution is the price of the schedule: weighted-average diluted shares up 28.8% in nine months on about $2.26 billion of issuance, with Q3 free cash outflow of $199.5 million.
- Values the option at roughly 400 times trailing sales after cash, so the position only works while the calendar keeps printing dates.
- Owns the scarcest input in the chain: HALEU enrichment backlog of $5.4 billion and $7.0 billion of total backlog through 2040.
- Signed the Oklo letter of intent for HALEU covering up to five Aurora powerhouses, with deliveries from 2029 and prepayments contemplated.
- Has begun commercial HALEU enrichment from its16-centrifuge cascade at Piketon, Ohio — the same county as Oklo's 1.2 GW Meta campus.
- Risk: the fiscal 2027 budget omits further funding for operating the HALEU cascade, putting about $0.8 billion of technical-solutions backlog in play.
- Ships components today: Q3 revenue of $953.0 million and net income of $101.7 million, so it gets paid on construction rather than on license milestones.
- Trades at about 3 times trailing sales against roughly 1,400 times for the developers, with components, fuel fabrication, medical isotopes and stockpile conversion work.
- Watch order timing: it sells into operating-plant and naval programs, so the AI-power pipeline reaches it with a lag of years.
- Already sells the electrons the developers promise: a 32.4 GW operating fleet on $31.3 billion of trailing revenue, about 2.8 times sales.
- Near-term catalyst is the Nov. 9, 2026 third-quarter report, including hyperscaler offtake commentary.
- Meta signed Constellation in 2025, and Google took a long-term deal on 890 MW of uprates, so the demand is contracted at the operating fleet.
- Contracted rather than promised: Meta will buy more than 2.1 GW from Perry and Davis-Besse plus 433 MW of uprates.
- Q2 revenue of $4.02 billion and net income of $305 million, about 2.2 times trailing sales, with the stock up 10.6% on Nov. 6.
- Life extensions and uprates sell electrons years before Oklo's first HALEU deliveries arrive in 2029.
- Funds the entire chain: $83.1 billion of capital expenditure over nine months and up to 6.6 GW of nuclear commitments announced in January 2026.
- Q3 revenue of $64.6 billion and net income of $9.86 billion, with Oklo's 1.2 GW Pike County campus the longest-dated piece of the basket.
- Watch free cash flow: it was negative $1.16 billion in the quarter as capital spending hit $33.9 billion, so nuclear purchases are a small line in a large budget.
- Approved design, negligible revenue: $281 thousand of quarterly revenue against a $43.7 million net loss.
- Diluted share count went from 163.7 million in Q4 2025 to 410.5 million in Q3 2026, and the stock remains about 84% below its 52-week high of $32.09.
- The Oct. 29 Doosan power-module first article is the one dated milestone that would break the bear case if it converts into a hyperscaler offtake.
- Builds the hardware into a cooling bid: the Nov. 6 close of KRW 44,700 was down 9.3% on the day and about 68% below the 52-week high of KRW 139,200.
- Operations improved — revenue of KRW 4.45 trillion, operating profit of KRW 261.2 billion, net loss narrowed to KRW 13.7 billion — and the stock fell for a third straight session.
- The Oct. 29 NuScale power-module first article at Changwon is the bull case; without hyperscaler offtake, component capacity is a long-dated cost.
